|
Sign In to gain access to subscriptions and/or personal tools.
|
The 50 Most-Frequently Cited Articles
in J Cardiovasc Pharmacol Ther as of August 1, 2008 -- updated monthly
Most-cited rankings are recalculated at the beginning of the month.
Rankings are based on citations to articles on this journal site from articles in HighWire-hosted journals.
| 6. |
D. Y. Li, H. J. Chen, E. D. Staples, K. Ozaki, B. Annex, B. K. Singh, R. Vermani, J. L. Mehtat |
 |
|
Oxidized Low-Density Lipoprotein Receptor LOX-1 and Apoptosis in Human Atherosclerotic Lesions |
|
|
J Cardiovasc Pharmacol Ther Sep 01, 2002; 7: 147-153.
(In "Article")
[Abstract]
[PDF]
|
|
|
| |
| 7. |
M. R. Cesarone, L. Incandela, M. T. DeSanctis, G. Belcaro, M. Dugall, G. Acerbi |
|
|
Variations in Plasma Free Radicals in Patients with Venous Hypertension with HR (Paroven, Venoruton; 0-(ß-hydroxyethyl)-rutosides): A Clinical, Prospective, Placebo-Controlled, Randomized Trial |
|
|
J Cardiovasc Pharmacol Ther Mar 01, 2002; 7: 25-28.
(In "Article")
[Abstract]
[PDF]
|
|
|
| |
| 8. |
Bramah N. Singh |
|
|
Atrial Fibrillation: Epidemiologic Considerations and Rationale for Conversion and Maintenance of Sinus Rhythm |
|
|
J Cardiovasc Pharmacol Ther Mar 01, 2003; 8: 13-26.
(In "Article")
[Abstract]
[PDF]
|
|
|
| |
| 9. |
Behzad Molavi, Neda Rasouli, Jawahar L. Mehta |
|
|
Peroxisome Proliferator-Activated Receptor Ligands as Antiatherogenic Agents: Panacea or Another Pandora's Box? |
|
|
J Cardiovasc Pharmacol Ther Mar 01, 2002; 7: 1-8.
(In "Article")
[Abstract]
[PDF]
|
|
|
| |
| 10. |
Keith E. Jackson, Martin Farias, Amber Stanfill, James L. Caffrey |
|
|
Delta Opioid Receptors Inhibit Vagal Bradycardia in the Sinoatrial Node |
|
|
J Cardiovasc Pharmacol Ther Dec 01, 2001; 6: 385-393.
(In "Article")
[Abstract]
[PDF]
|
|
|
| |
|
[Previous 5 Articles]
[Next 5 Articles]
|
Last Updated: 08/04/2008 05:03:54
|
